Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein InhibitorXiufang Zheng, Hongying Yun, Kunlun Xiang et al.|Journal of Medicinal Chemistry|2019Cited by 96